Tyrosine kinase inhibitors may change the metastatic pattern. [electronic resource]
Producer: 20131119Description: 544 p. digitalISSN:- 1107-0625
- Adenocarcinoma -- drug therapy
- Adenocarcinoma of Lung
- Antineoplastic Agents -- therapeutic use
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Middle Aged
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Skin Neoplasms -- secondary
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.